Джозеф Меркола - Кето-навигатор

64. DiNicolantonio JJ, Niazi AK, O’Keefe JH, Lavie CJ. Explaining the recent fish oil trial “failures”. J Glycomics Lipidomics . 2013; 3 (1): e112. doi:10.4172/2153-0637.1000e112.

65. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989 Sep 30; 2 (8666): 757–761.

66. Burr ML, Sweetham PM, Fehily AM. Diet and reinfarction. Eur Heart J . 1994 Aug; 15 (8): 1152–1153.

67. Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002 Apr 23; 105 (16): 1897–1903.

68. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet. 1999 Aug 7; 354 (9177): 447–455.

69. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008 Oct 4; 372 (9645): 1223–1230.

70. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007 Mar 31; 369 (9567): 1090–1098.

71. Там же.

72. Tanaka K, Ishikawa Y, Yokoyama M, et al. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: subanalysis of the JELIS trial. Stroke . 2008 Jul; 39 (7): 2052–2058.

73. Einvik G, Klemsdal TO, Sandvik L, et al. A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk. Eur J Cardiovasc Prev Rehabil . 2010 Oct; 17 (5): 588–592.

74. Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother . 2002 Oct; 56 (8): 365–379.

75. DiNicolantonio JJ, Meier P, O’Keefe JH. Omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease: do formulation, dosage & comparator matter? Mo Med . 2013 Nov-Dec; 110 (6): 495–498.

76. Simopoulos AP, Leaf A, Salem N Jr. Essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. Ann Nutr Metab . 1999; 43 (2): 127–130.

77. Harris WS, Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med . 2004 Jul; 39 (1): 212–220.

1. Lee KW, Lee HJ, Cho HY, et al. Role of the conjugated linoleic acid in the prevention of cancer. Crit Rev Food Sci Nutr . 2005; 45 (2): 135–144.

2. Wang Y, Lu J, Ruth MR, et al. Trans-11 vaccenic acid dietary supplementation induces hypolipidemic effects in JCR: LA-cp rats. J Nutr . 2008 Nov; 138 (1): 2117–2122.

3. Micha R, Mozaffarian D. Trans fatty acids: effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids . 2008; 79 (3–5): 147–152.

4. Kinsella JE, Bruckner G, Mai J, et al. Metabolism of trans fatty acids with emphasis on the effects of trans, trans-octadecadienoate on lipid composition, essential fatty acid, and prostaglandins: an overview. Am J Clin Nutr . 1981 Oct; 34 (1): 2307–2318.

5. Tardy AL, Morio B, Chardigny JM, et al. Ruminant and industrial sources of trans-fat and cardiovascular and diabetic diseases. Nut Res Rev . 2011 Jun; 24 (1): 111–117.

6. Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol . 2003 Feb; 60 (2): 194–200.

7. Chavarro JE, Stampfer MJ, Campos H, et al. A prospective study of trans-fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev . 2008 Jan; 17 (1): 95–101.

8. Chajes V, Thiebaut AC, Rotival M, et al. Association between serum transmonounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol . 2008 Jun 1; 167 (11): 1312–1320.

9. Phivilay A, Julien C, Tremblay C, et al. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer’s disease. Neuroscience 2009 Mar 3; 159 (1): 296–307.

10. Golomb BA, Bui AK. A fat to forget: trans fat consumption and memory. PLoS One . 2015 Jun 17; 10 (6): e0128129.

11. Sanchez-Villegas A, Verberne L, De Irala J, et al. Dietary fat intake and the risk of depression: the SUN Project. PLoS One . 2011 Jan 26; 6 (1): e16268.

12. A scientific discovery which will affect every kitchen in America. Ladies Home Journal . 2012:45. Доступно по адресу https://hdl.handle.net/2027/mdp.39015011414177?urlappend=%3Bseq=53.1177-9.

13. Rupp, R. The butter wars: when margarine was pink. Nat Geographic [Интернет]. 2014 Aug 13 [открыто 4 июня 2018]. Доступно по адресу http://theplate.nationalgeographic.com/2014/08/13/the-butter-wars-when-margarine-was-pink.

14. Braun, AD. Save Waste Fats. Atlantic [Интернет]. 2014 Apr 18 [открыто 4 июня 2018]. Доступно по адресу http://www.theatlantic.com/health/archive/2014/04/reluctantly-turning-bacon-into-bombs-during-world-war-ii/360298/.

15. History of the American Heart Association. Am Heart Assn . [Интернет] [открыто 4 июня 2018]. Available from http://www.heart.org/HEARTORG/General/History-of-the-American-Heart-Association_UCM_308120_Article.jsp?appName=MobileApp.

16. Enig, M, Fallon S. Eat fat, lose fat: the healthy alternative to trans fats . New York (NY): Penguin; 2004. 304 p.

17. Christakis, G. The anti-coronary club. A dietary approach to the prevention of coronary heath disease: a seven-year report. Am J Pub Health . 1966 Feb; 56 (2): 299–314. Доступно по адресу http://www.epi.umn.edu/cvdepi/studysynopsis/anti-coronary-club-trial.

18. Christakis G, Rinzler SH, Archer M, et al. Effect of the Anti-Coronary Club program on coronary heart disease. Risk-factor status. JAMA . 1966 Nov 7; 198 (6): 597–604.

19. Johnston PV, Johnson OC, Kummerow FA. Occurrence of trans fatty acids in human tissue. Science. 1957 Oct 11; 126 (3296): 698–699.

20. Kummerow FA, et al. The influence of three sources of dietary fats and cholesterol on lipid composition of swine serum lipids and aorta tissue. Artery 4. 1978: 360–384.

21. Schleifer D. We spent a million bucks and then we had to do something: the unexpected implications of industry involvement in trans fat research [Интернет]. Bull of Science, Tech & Soc . 2011 Oct 4 [открыто 4 июня 2018]; 31 (6): 460–471. Доступно по адресу http://journals.sagepub.com/doi/abs/10.1177/0270467611422837

22. Guidance for industry: trans fatty acids in nutrition labeling, nutrient content claims, health claims; small entity compliance guide [Интернет]. FDA. 2018 Aug [открыто 4 июня 2018]. Доступно по адресу http://www.fda.gov/RegulatoryInformation/Guidances/ucm053479.htm.

23. AMA supports ban of artificial trans fats in restaurants and bakeries nationwide. AMA . 2008 Press release, 2008 Nov 10 [accessed 2 June 2009]. Available from http://www.ama-assn.org/ama/pub/category/20273.html.